{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:43:14Z","timestamp":1784198594571,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1007\/s10434-000-0087-9","type":"journal-article","created":{"date-parts":[[2005,2,25]],"date-time":"2005-02-25T20:56:04Z","timestamp":1109364964000},"page":"87-97","source":"Crossref","is-referenced-by-count":419,"title":["Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)"],"prefix":"10.1007","volume":"7","author":[{"given":"Charles M.","family":"Balch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seng-jaw","family":"Soong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merrick I.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall M.","family":"Urist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine P.","family":"Karakousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walley J.","family":"Temple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Mihm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond L.","family":"Barnhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Jewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J.","family":"Wanebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Investigators From the Intergroup Melanoma Surgical Trial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00000658-197812000-00004","volume":"188","author":"CM Balch","year":"1978","unstructured":"Balch CM, Murad TM, Soong SJ, Ingalls AL, Halpern NB, Maddox WA. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark?s and Breslow?s staging methods. Ann Surg 1978;188:732?742.","journal-title":"Ann Surg"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/00000658-197511000-00007","volume":"182","author":"A Breslow","year":"1975","unstructured":"Breslow A. Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma. Ann Surg 1975;182:572?575.","journal-title":"Ann Surg"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00000658-198309000-00014","volume":"198","author":"DS Reintgen","year":"1983","unstructured":"Reintgen DS, Cox EG, McCarty KSJ, Vollmer RT, Seigler HF. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg 1983;198:379?385.","journal-title":"Ann Surg"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00000658-198212001-00011","volume":"196","author":"CM Balch","year":"1982","unstructured":"Balch CM, Soong SJ, Milton GW, et al. A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg 1982;196:677?684.","journal-title":"Ann Surg"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00000658-197509000-00013","volume":"182","author":"HJ Wanebo","year":"1975","unstructured":"Wanebo HJ, Fortner JG, Woodruff J, MacLean B, Binkowski E. Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: use of the combined microstage technique (Clark-Breslow). Ann Surg 1975;182:302?314.","journal-title":"Ann Surg"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/1097-0142(197903)43:3<883::AID-CNCR2820430316>3.0.CO;2-V","volume":"43","author":"CM Balch","year":"1979","unstructured":"Balch CM, Murad TM, Soong SJ, Ingalls AL, Richards PC, Maddox WA. Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer 1979;43:883?888.","journal-title":"Cancer"},{"key":"CR7","first-page":"343","volume":"86","author":"CM Balch","year":"1979","unstructured":"Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA. A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery 1979;86:343?351.","journal-title":"Surgery"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00000658-199609000-00002","volume":"224","author":"CM Balch","year":"1996","unstructured":"Balch CM, Soong SJ, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996;224:255?263.","journal-title":"Ann Surg"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00000658-199309000-00005","volume":"218","author":"CM Balch","year":"1993","unstructured":"Balch CM, Urist MM, Karakousis CP, et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm): results of a multi-institutional randomized surgical trial. Ann Surg 1993;218:262?267.","journal-title":"Ann Surg"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJM197905313002203","volume":"300","author":"M Zelen","year":"1979","unstructured":"Zelen M. A new design for randomized clinical trials. N Engl J Med 1979;300:1242?1245.","journal-title":"N Engl J Med"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1056\/NEJM197709222971202","volume":"297","author":"U Veronesi","year":"1977","unstructured":"Veronesi U, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med 1977;297:627?630.","journal-title":"N Engl J Med"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/1097-0142(197803)41:3<948::AID-CNCR2820410324>3.0.CO;2-Z","volume":"41","author":"FH Sim","year":"1978","unstructured":"Sim FH, Taylor WF, Ivins JC, Pritchard DJ, Soule EH. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma: preliminary results. Cancer 1978;41:948?956.","journal-title":"Cancer"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0025-6196(12)62768-2","volume":"62","author":"FH Sim","year":"1986","unstructured":"Sim FH, Taylor WF, Pritchard DJ, Soule EH. Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc 1986;62:697?705.","journal-title":"Mayo Clin Proc"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/1097-0142(19820601)49:11<2420::AID-CNCR2820491133>3.0.CO;2-2","volume":"49","author":"U Veronesi","year":"1982","unstructured":"Veronesi U, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection in stage I melanoma of the skin of the lower extremities. Cancer 1982;49:2420?2430.","journal-title":"Cancer"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1200\/JCO.1988.6.1.163","volume":"6","author":"CM Balch","year":"1988","unstructured":"Balch CM. The role of elective lymph node dissection in melanoma: rationale, results, and controversies. J Clin Oncol 1988;6:163?172.","journal-title":"J Clin Oncol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF02303492","volume":"5","author":"CM Balch","year":"1998","unstructured":"Balch CM. Surgical management of melanoma: results of prospective randomized trials. Ann Surg Oncol 1998;5:301?309.","journal-title":"Ann Surg Oncol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(97)08260-3","volume":"351","author":"N Cascinelli","year":"1998","unstructured":"Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial. Lancet 1998;351:793?796.","journal-title":"Lancet"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s10434-999-0144-y","volume":"6","author":"FF Haddad","year":"1999","unstructured":"Haddad FF, Stall A, Messina J, et al. The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion. Ann Surg Oncol 1999;6:144?149.","journal-title":"Ann Surg Oncol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1200\/JCO.1998.16.6.2253","volume":"16","author":"JE Gershenwald","year":"1998","unstructured":"Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998;16:2253?2260.","journal-title":"J Clin Oncol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ssu.2980080611","volume":"8","author":"CM Balch","year":"1992","unstructured":"Balch CM. Cutaneous melanoma: prognosis and treatment results worldwide. Semin Surg Oncol 1992;8:400?414.","journal-title":"Semin Surg Oncol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/1097-0142(19880915)62:6<1207::AID-CNCR2820620628>3.0.CO;2-A","volume":"62","author":"FLJ Meyskens","year":"1988","unstructured":"Meyskens FLJ, Berdeaux DH, Parks B, Tong T, Loescher L, Moon TE. Cutaneous malignant melanoma (Arizona Cancer Center experience). I. Natural history and prognostic factors influencing survival in patients with stage I disease. Cancer 1988;62:1207?1214.","journal-title":"Cancer"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/archderm.134.8.983","volume":"134","author":"S Mraz-Gernhard","year":"1998","unstructured":"Mraz-Gernhard S, Sagebiel RW, Kashani-Sabet M, Miller JR, Leong SPL. Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma. Arch Dermatol 1998;134:983?987.","journal-title":"Arch Dermatol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF02071520","volume":"16","author":"SJ Soong","year":"1992","unstructured":"Soong SJ, Shaw HM, Balch CM, McCarthy WH, Urist MM, Lee JY. Predicting survival and recurrence in localized melanoma: a multivariate approach. World J Surg 1992;16:191?195.","journal-title":"World J Surg"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7326\/0003-4819-125-5-199609010-00003","volume":"125","author":"L Schuchter","year":"1996","unstructured":"Schuchter L, Schultz DJ, Synnestvedt M, et al. A prognostic model for predicting 1-year survival in patients with primary melanoma. Ann Intern Med 1996;125:369?375.","journal-title":"Ann Intern Med"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/sim.4780040305","volume":"4","author":"N Cascinelli","year":"1985","unstructured":"Cascinelli N, Marubini E, Morabito A, Bufalino R. Prognostic factors for stage I melanoma of the skin: a review. Stat Med 1985;4:265?278.","journal-title":"Stat Med"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/1097-0142(19940115)73:2<336::AID-CNCR2820730217>3.0.CO;2-W","volume":"73","author":"LA Wanek","year":"1994","unstructured":"Wanek LA, Elashoff RM, Goradia TM, Morton DL, Cochran AJ. Application of multistage Markov modeling to malignant melanoma progression. Cancer 1994;73:336?343.","journal-title":"Cancer"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8<1426::AID-CNCR9>3.0.CO;2-C","volume":"80","author":"S Sahin","year":"1997","unstructured":"Sahin S, Rao B, Kopf AW, et al. Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model. Cancer 1997;80:1426?1431.","journal-title":"Cancer"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00008390-199211000-00008","volume":"2","author":"DW Hein","year":"1992","unstructured":"Hein DW, Moy RL. Elective lymph node dissection in stage I malignant melanoma: a meta-analysis. Melanoma Res 1992;2:273?277.","journal-title":"Melanoma Res"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-3-642-78771-3_25","volume":"139","author":"R Rompel","year":"1995","unstructured":"Rompel R, Garbe C, Buttner P, Teichelmann K, Petres J. Role of elective lymph node dissection in stage I malignant melanoma: evaluation by matched pair analysis. Recent Results Cancer Res 1995;139:323?336.","journal-title":"Recent Results Cancer Res"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1001\/archderm.1983.01650340026014","volume":"119","author":"C Kuehnl-Petzoldt","year":"1983","unstructured":"Kuehnl-Petzoldt C, Wiebelt H, Berger H. Prognostic groups of patients with stage I melanoma. Arch Dermatol 1983;119:816?819.","journal-title":"Arch Dermatol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/1097-0142(19950515)75:10<2499::AID-CNCR2820751016>3.0.CO;2-8","volume":"75","author":"P Buttner","year":"1995","unstructured":"Buttner P, Garbe C, Bertz J, et al. Primary cutaneous melanoma: optimized cutoff points of tumor thickness and importance of Clark?s level for prognostic classification. Cancer 1995;75:2499?2506.","journal-title":"Cancer"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1067\/msy.1998.91269","volume":"124","author":"BJ Averbook","year":"1998","unstructured":"Averbook BJ, Russo LJ, Mansour EG. A long-term analysis of 620 patients with malignant melanoma at a major referral center. Surgery 1998;124:746?756.","journal-title":"Surgery"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1200\/JCO.1997.15.3.1039","volume":"15","author":"AC Buzaid","year":"1997","unstructured":"Buzaid AC, Ross MI, Balch CM, et al. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol 1997;15:1039?1051.","journal-title":"J Clin Oncol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/1097-0142(19950515)75:10<2484::AID-CNCR2820751014>3.0.CO;2-U","volume":"75","author":"C Garbe","year":"1995","unstructured":"Garbe C, Buttner P, Bertz J, et al. Primary cutaneous melanoma: identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer 1995;75:2484?2491.","journal-title":"Cancer"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/jnci\/86.10.761","volume":"86","author":"M Thorn","year":"1994","unstructured":"Thorn M, Ponten F, Bergstrom R, Sparen P, Adami HO. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden. J Natl Cancer Inst 1994;86:761?769.","journal-title":"J Natl Cancer Inst"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1002\/1097-0142(19800615)45:12<3012::AID-CNCR2820451223>3.0.CO;2-O","volume":"45","author":"CM Balch","year":"1980","unstructured":"Balch CM, Wilkerson JA, Murad TM, Soong SJ, Ingalls AL, Maddox WA. The prognostic significance of ulceration of cutaneous melanoma. Cancer 1980;45:3012?3017.","journal-title":"Cancer"},{"key":"CR37","doi-asserted-by":"crossref","unstructured":"Essner R, Conforti A, Kelley MC, et al. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol (in press)","DOI":"10.1007\/s10434-999-0442-4"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0190-9622(92)70068-Q","volume":"26","author":"KA Vossaert","year":"1992","unstructured":"Vossaert KA, Silverman MK, Kopf AW, et al. Influence of gender on survival in patients with stage I malignant melanoma. J Am Acad Dermatol 1992;26:429?440.","journal-title":"J Am Acad Dermatol"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","volume":"83","author":"AE Chang","year":"1998","unstructured":"Chang AE, Karnell LH, Menck HR. The National Cancer Center Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. Cancer 1998;83:1664?1668.","journal-title":"Cancer"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/BF02303614","volume":"1","author":"PF Austin","year":"1994","unstructured":"Austin PF, Cruse CW, Lyman G, Schroer K, Glass F, Reintgen DS. Age as a prognostic factor in the malignant melanoma population. Ann Surg Oncol 1994;1:487?494.","journal-title":"Ann Surg Oncol"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","volume":"14","author":"JM Kirkwood","year":"1996","unstructured":"Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996;14:7?17.","journal-title":"J Clin Oncol"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/1097-0142(19950101)75:1<34::AID-CNCR2820750108>3.0.CO;2-0","volume":"75","author":"MK Wallack","year":"1995","unstructured":"Wallack MK, Sivanandham M, Balch CM, et al. A phase III randomized, double-blind multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma. Cancer 1995;75:35?42.","journal-title":"Cancer"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00000658-198308000-00009","volume":"198","author":"CM Balch","year":"1983","unstructured":"Balch CM, Durant JR, Bartolucci AA. The impact of surgical quality control in multi-institutional group trials involving adjuvant cancer treatments. Ann Surg 1983;198:164?167.","journal-title":"Ann Surg"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","volume":"127","author":"DL Morton","year":"1992","unstructured":"Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392?399.","journal-title":"Arch Surg"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00000658-199110000-00013","volume":"214","author":"DL Morton","year":"1991","unstructured":"Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Ann Surg 1991;214:491?501.","journal-title":"Ann Surg"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00000658-198201001-00006","volume":"195","author":"CLJ Day","year":"1982","unstructured":"Day CLJ, Mihm MCJ, Lew RA, et al. Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51?3.39 mm): a conceptual model for tumor growth and metastasis. Ann Surg 1982;195:35?43.","journal-title":"Ann Surg"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/02844319509034330","volume":"29","author":"J Lock-Andersen","year":"1995","unstructured":"Lock-Andersen J, Hou-Jensen K, Hansen J, Jensen NK, Sogaard H, Andersen PK. Observer variation in histological classification of cutaneous malignant melanoma. Scand J Plast Reconstr Surg Hand Surg 1995;29:141?148.","journal-title":"Scand J Plast Reconstr Surg Hand Surg"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1200\/JCO.1996.14.4.1218","volume":"14","author":"R Corona","year":"1996","unstructured":"Corona R, Mele A, Amini M, et al. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol 1996;14:1218?1223.","journal-title":"J Clin Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10434-000-0087-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10434-000-0087-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10434-000-0087-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T12:51:40Z","timestamp":1559134300000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10434-000-0087-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["87"],"URL":"https:\/\/doi.org\/10.1007\/s10434-000-0087-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}